Promacta tended to boost platelet counts in patients with low-risk MDS, and helped those patients be independent of transfusions, too. Promacta (eltrombopag) improved platelet counts in patients with ...

Platelet transfusion in neonates and children varies widely, with donor and processing factors linked to lower platelet increments and higher transfusion burden but not to mortality or length of stay.

Researchers may be one step closer to improving treatments for bleeding disorders. They have devised a way to maximize the numbers and function of clot-forming blood cells from mice. Researchers may ...

A group of 12 thrombocytopenic patients, ranging in age from two to fourteen years, were studied. The thrombocytopenia was due to diverse conditions (Table 1). The platelet count ranged from 3000 to ...

DURING studies of blood viscosity with a method designed to determine resistance to flow in very small blood vessels, it was unexpectedly found that very high pressures became necessary to force blood ...

Platelet transfusion thresholds in according bleeding risk and the presence of bleeding. WHO = World Health Organization. “In practice, we see all too often [that] prophylactic transfusion of ...

Turbulence is a critical physical factor that promotes the large-scale production of functional platelets from human induced pluripotent stem cells, researchers reportl. Exposure to turbulent energy ...